Alaiwi et al. report that of 1829 patients with RCC who were provided germline genetic testing, pathogenic or likely pathogenic variants in the FH gene were more common in AA patients, while the CHEK2 gene was more common in non-African patients [44]. The gene discussed is FH; the disease is renal cell carcinoma.